It might seem counterintuitive, but stocks that fall and fall don't tend to get bought up. They are cheap for a reason. On the other hand, expensive biotech is expensive for a reason. Smart money knows which companies big pharma would really like to aquire and they bid those ones up into what seems like the stratosphere to most retail traders. Of course, there are exceptions, but the vast number of cheap biotechs are cheap because there's no real indication yet that they're doing breakthrough science.
Amen, hedger! Well said. But let me add one bit of advice. If you are buying to invest for the long term, do it with conviction. So, why would you be willing to invest at $4 but not $3? If I have strong conviction that a stock is worth $4, I'd much rather be buying it for $3.
$8? What happened to $30? Oh, well. It's all good. As long as we keeping buying bigger amounts than we bought at $10 and $8 and $6, we'll all be filthy rich.
IBB pullback to 50 day ema. Doesn't really look that "toppy" to me at the last 52 wk highs. So, I don't think it's over yet. But, ONVO is it's own beast now. Hasn't bee getting any love from sector buying programs for awhile.
Yeah they should've done it 2 years ago when stock was $10.
But, in my view company is still way overvalued. Should be a $50-100M market cap.
Wall st. just can't get enough ONVO. The only reason they pushing it down is to get more and more at lower prices. Greed is a good thing.
I think they tried selling the printer in the beginning, but nobody bought one.
Google "EnvisionTEC sells 3D Bio-Printer under 200K" just for laughs
Saw something over the weekend...Benzinga exclusive interview with Murph. Haha!
Really, what more can he do to pump this stock? Each new pump has less positive effect than the last. Next one I can see actually tanking the stock.
Tradesman, no mental challenge here, I just wanted to alert others to the manipulation and the misinformation campaign that has occurred. But it was probably a lost cause. Few listened and many lost money.
Cashmoo might be interested but Cheetos is a deal breaker. She only shares a box with classy gentlemen who wax their mustache and grease their hair, mask their body odor with polo green and serve a proper curry with rice.
Sure, the sentiment will probably turn again, but to what extent?
And the market is a beast unto itself so there's no guarantee that the price of your stock will respond to a new shift in sentiment. Or it may reflect a new sentiment only with marginal gains. Because, market is supply/demand based ultimately. Sentiment can be positive but with too much supply, the market will not rally substantially....
So betting on sentiment is a #$%$ shoot. I'd rather bet that the company underperforms and sentiment doesn't improve. In that situation, sentiment just keeps getting worse and the stock declines. Vicious cycle/downward spiral.
What you say about sentiment is 100% true. You just have the cause and effect mixed up.
In other words, first came the pump, then the dump. It's not the other way around.
did Presnell execute at Tengion?
Ultimately, biotech comes down to the science. Sure, maybe Murph can execute and throw together a team to work on the next cancer drug. But that takes many years if not decades of work to get to a drug to market.